WQ
ENZ

Wealth Quarterback’s Enzo Biochem, Inc. ENZ Stock Holding History

Wealth Quarterback’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-500
Closed -$1.26K – 825
2020
Q1 		$1.26K Buy
+500
New +$1.23K ﹤0.01% 802

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Wealth Quarterback's ENZ Position: Q2 2020 in Review

Wealth Quarterback sold out of Enzo Biochem, Inc. (ENZ) in Q2 2020, closing a stake of 500 shares — an estimated $1.26K sold.

Wealth Quarterback first reported a position in ENZ in Q1 2020 and held it in 1 quarter. The position peaked at $1.26K in Q1 2020. 84 funds tracked by Wall St. Rank hold ENZ as of Q2 2020.

  • Wealth Quarterback reported no remaining Enzo Biochem, Inc. position as of Q2 2020 after selling out during the quarter.
  • Wealth Quarterback sold 500 Enzo Biochem, Inc. shares in Q2 2020, an estimated $1.26K.
  • Wealth Quarterback first reported a position in Enzo Biochem, Inc. in Q1 2020 and held it in 1 quarter.
  • Wealth Quarterback's Enzo Biochem, Inc. position peaked at $1.26K in Q1 2020.
  • 84 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2020.

Based on Wealth Quarterback's 13F filing for Q2 2020, filed 17 Aug 2020.